Document is current
Any future updates will be listed below
-
Authors
Zendjebil, Sandra
Steg, Philippe Gabriel
- License Information
-
More Information
Article History
Accepted: 22 September 2024
First Online: 10 October 2024
Declarations
:
: SZ has no conflict of interest to declare. PGS discloses the following: receiving research grants from Amarin, Sanofi; receiving honorara for clinical trials from Amarin, Amgen, AstraZeneca, Bayer, Bristol-Myers Squibb, Idorsia, Janssen, Novartis, Novo-Nordisk, Pfizer, Sanofi, for consulting or speaking from Amarin, Amgen, BMS, Novo-Nordisk. PGS is Chief Medical Officer at Bioquantis and Senior Associate Editor at Circulation. PGS is coinventor on a patent for the use of Alirocumab to reduce cardiovascular risks (all rights and royalties assigned to Sanofi).
: Not applicable.
